122 related articles for article (PubMed ID: 12739334)
1. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in bronchopulmonary and pleural cancers].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S23-41. PubMed ID: 12739334
[No Abstract] [Full Text] [Related]
2. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Technical bases and regulatory principles].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S18-22. PubMed ID: 12739333
[No Abstract] [Full Text] [Related]
3. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in skin and ocular melanoma].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S42-6. PubMed ID: 12739335
[No Abstract] [Full Text] [Related]
4. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S88-95. PubMed ID: 12739340
[No Abstract] [Full Text] [Related]
5. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S67-79. PubMed ID: 12739338
[No Abstract] [Full Text] [Related]
6. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in sarcomas].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S96-102. PubMed ID: 12739341
[No Abstract] [Full Text] [Related]
7. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in unknown primary neoplasms].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S103-4. PubMed ID: 12739342
[No Abstract] [Full Text] [Related]
8. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in gynecological neoplasms].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S47-55. PubMed ID: 12739336
[No Abstract] [Full Text] [Related]
9. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S56-66. PubMed ID: 12739337
[No Abstract] [Full Text] [Related]
10. [2002 Standards, Options and Recommendations for the use of [18F]-FDG (PET-FDG) in cancerology].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S1-109. PubMed ID: 12744225
[No Abstract] [Full Text] [Related]
11. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
[No Abstract] [Full Text] [Related]
12. [Standards, Options and Recommendations 2002 for the use of Positron Emission Tomography with [18F]-FDG (PET-FDG in cancerology (integral connection].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S5-17. PubMed ID: 12739332
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Glut-1 glucose transporter expression with.
Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
[TBL] [Abstract][Full Text] [Related]
14. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET.
Schaffler GJ; Wolf G; Schoellnast H; Groell R; Maier A; Smolle-Jüttner FM; Woltsche M; Fasching G; Nicoletti R; Aigner RM
Radiology; 2004 Jun; 231(3):858-65. PubMed ID: 15105451
[TBL] [Abstract][Full Text] [Related]
15. [Update of 'standards, options and recommendations' for FDG-PET in breast and gynaecological cancers].
Talbot JN; Grahek D
Gynecol Obstet Fertil; 2006 May; 34(5):434-6. PubMed ID: 16677841
[No Abstract] [Full Text] [Related]
16. Prognostic value of FDG PET imaging in malignant pleural mesothelioma.
Ng DC; Hain SF; O'Doherty MJ; Dussek J
J Nucl Med; 2000 Aug; 41(8):1443-4. PubMed ID: 10945542
[No Abstract] [Full Text] [Related]
17. [Contribution of positron emission tomography for the management of lung cancer].
Bury T; Rigo P
Rev Pneumol Clin; 2000 Apr; 56(2):125-31. PubMed ID: 10810198
[TBL] [Abstract][Full Text] [Related]
18. Talc pleurodesis mimics pleural metastases: differentiation with positron emission tomography/computed tomography.
Weiss N; Solomon SB
Clin Nucl Med; 2003 Oct; 28(10):811-4. PubMed ID: 14508271
[TBL] [Abstract][Full Text] [Related]
19. Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography.
Kung J; Zhuang H; Yu JQ; Duarte PS; Alavi A
Clin Nucl Med; 2003 Dec; 28(12):975-6. PubMed ID: 14663319
[No Abstract] [Full Text] [Related]
20. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
Laking G; Price P
Thorax; 2001 Sep; 56 Suppl 2(Suppl 2):ii38-44. PubMed ID: 11514705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
